410 related articles for article (PubMed ID: 31681561)
1. IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer.
Kourko O; Seaver K; Odoardi N; Basta S; Gee K
Front Oncol; 2019; 9():969. PubMed ID: 31681561
[TBL] [Abstract][Full Text] [Related]
2. IL-12 Family Cytokines in Cancer and Immunotherapy.
Mirlekar B; Pylayeva-Gupta Y
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33418929
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.
Ganea D
Adv Neuroimmunol; 1996; 6(1):61-74. PubMed ID: 8790782
[TBL] [Abstract][Full Text] [Related]
4. Harnessing cytokines and chemokines for cancer therapy.
Propper DJ; Balkwill FR
Nat Rev Clin Oncol; 2022 Apr; 19(4):237-253. PubMed ID: 34997230
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of cancer by IL-12-based cytokine combinations.
Weiss JM; Subleski JJ; Wigginton JM; Wiltrout RH
Expert Opin Biol Ther; 2007 Nov; 7(11):1705-21. PubMed ID: 17961093
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy.
Yang Y; Lundqvist A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266177
[TBL] [Abstract][Full Text] [Related]
8. The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.
Fournié JJ; Poupot M
Front Immunol; 2018; 9():2506. PubMed ID: 30416507
[TBL] [Abstract][Full Text] [Related]
9. The IL-2 cytokine family in cancer immunotherapy.
Sim GC; Radvanyi L
Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
[TBL] [Abstract][Full Text] [Related]
10. Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential.
Jou E
Explor Target Antitumor Ther; 2023; 4(3):474-497. PubMed ID: 37455828
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
12. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
13. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
Qu X; Tang Y; Hua S
Front Immunol; 2018; 9():563. PubMed ID: 29662489
[TBL] [Abstract][Full Text] [Related]
14. Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15.
Sheikhi A; Jafarzadeh A; Kokhaei P; Hojjat-Farsangi M
Iran J Immunol; 2016 Sep; 13(3):148-66. PubMed ID: 27671507
[TBL] [Abstract][Full Text] [Related]
15. Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy.
Mirlekar B
SAGE Open Med; 2022; 10():20503121211069012. PubMed ID: 35096390
[TBL] [Abstract][Full Text] [Related]
16. IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation - a comprehensive review.
Rallis KS; Corrigan AE; Dadah H; Stanislovas J; Zamani P; Makker S; Szabados B; Sideris M
Future Oncol; 2022 Sep; 18(29):3349-3365. PubMed ID: 36172856
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
Front Immunol; 2018; 9():2905. PubMed ID: 30619269
[TBL] [Abstract][Full Text] [Related]
18. The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.
Wasmer MH; Krebs P
Front Immunol; 2016; 7():682. PubMed ID: 28119694
[TBL] [Abstract][Full Text] [Related]
19. The Role of IL-33/ST2 Pathway in Tumorigenesis.
Larsen KM; Minaya MK; Vaish V; Peña MMO
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
[TBL] [Abstract][Full Text] [Related]
20. Biology of IL-2 and its therapeutic modulation: Mechanisms and strategies.
Mitra S; Leonard WJ
J Leukoc Biol; 2018 Apr; 103(4):643-655. PubMed ID: 29522246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
